{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:50:08Z","timestamp":1788587408910,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571703"],"award-info":[{"award-number":["81571703"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Outstanding Young Talents Program of Shanghai Municipal Commission of Health and Family Planning","award":["2017YQ027"],"award-info":[{"award-number":["2017YQ027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12149-019-01374-5","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T09:03:19Z","timestamp":1559725399000},"page":"647-656","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["18F-FDG PET\/CT imaging in pulmonary sarcomatoid carcinoma and correlation with clinical and genetic findings"],"prefix":"10.1007","volume":"33","author":[{"given":"Xiaodong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huoqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9479-132X","authenticated-orcid":false,"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"key":"1374_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.surg.2012.05.007","volume":"152","author":"S Yendamuri","year":"2012","unstructured":"Yendamuri S, Caty L, Pine M, Adem S, Bogner P, Miller A, et al. Outcomes of sarcomatoid carcinoma of the lung: a surveillance, epidemiology, and end results database analysis. Surgery. 2012;152:397\u2013402.","journal-title":"Surgery"},{"key":"1374_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.biopha.2015.10.009","volume":"76","author":"L Gu","year":"2015","unstructured":"Gu L, Xu Y, Chen Z, Pan Y, Lu S. Clinical analysis of 95 cases of pulmonary sarcomatoid carcinoma. Biomed Pharmacother. 2015;76:134\u201340.","journal-title":"Biomed Pharmacother"},{"key":"1374_CR3","first-page":"405","volume":"49","author":"RJ Avila Mart\u00ednez","year":"2013","unstructured":"Avila Mart\u00ednez RJ, Marr\u00f3n Fern\u00e1ndez C, Hermoso Alarza F, Zuluaga Bedoya M, Meneses Pardo JC, G\u00e1mez Garc\u00eda AP. Primary pulmonary sarcomatoid carcinoma. Arch Bronconeumol. 2013;49:405\u20137.","journal-title":"Arch Bronconeumol"},{"key":"1374_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pneumo.2011.05.006","volume":"68","author":"N Paleiron","year":"2012","unstructured":"Paleiron N, Tromeur C, Gut-Gobert C, Andr\u00e9 N, Quiot JJ, Quintin-Rou\u00e9 I, et al. Pulmonary sarcomatoid carcinoma: clinical and prognostic characteristics, a case report. Rev Pneumol Clin. 2012;68:27\u201330.","journal-title":"Rev Pneumol Clin"},{"key":"1374_CR5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10:1243\u201360.","journal-title":"J Thorac Oncol"},{"key":"1374_CR6","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s00259-013-2672-8","volume":"41","author":"S Takeuchi","year":"2014","unstructured":"Takeuchi S, Khiewvan B, Fox PS, Swisher SG, Rohren EM, Bassett RL Jr, et al. Impact of initial PET\/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2014;41:906\u201314.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1374_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrclinonc.2015.75","volume":"12","author":"W Grootjans","year":"2015","unstructured":"Grootjans W, de Geus-Oei LF, Troost EG, Visser EP, Oyen WJ, Bussink J. PET in the management of locally advanced and metastatic NSCLC. Nat Rev Clin Oncol. 2015;12:395\u2013407.","journal-title":"Nat Rev Clin Oncol"},{"key":"1374_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/RTI.0b013e3182128704","volume":"26","author":"MT Truong","year":"2011","unstructured":"Truong MT, Viswanathan C, Erasmus JJ. Positron emission tomography\/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response. J Thorac Imaging. 2011;26:132\u201346.","journal-title":"J Thorac Imaging"},{"key":"1374_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s12149-018-1301-9","volume":"32","author":"H Anwar","year":"2018","unstructured":"Anwar H, Vogl TJ, Abougabal MA, Gr\u00fcnwald F, Kleine P, Elrefaie S, et al. The value of different 18F-FDG PET\/CT baseline parameters in risk stratification of stage I surgical NSCLC patients. Ann Nucl Med. 2018;32:687\u201394.","journal-title":"Ann Nucl Med"},{"key":"1374_CR10","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/RLU.0b013e31823ea47f","volume":"37","author":"A Ciarallo","year":"2012","unstructured":"Ciarallo A, Makis W, Novales-Diaz JA, Lisbona R. Sarcomatoid carcinoma (carcinosarcoma) of the lung mimics malignant pleural mesothelioma on 18F-FDG PET\/CT: a report of 2 cases. Clin Nucl Med. 2012;37:416\u20139.","journal-title":"Clin Nucl Med"},{"key":"1374_CR11","first-page":"268","volume":"18","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Li B, Shi H, Cai L, Gu Y. Sarcomatoid carcinoma of the lung mimics aspergilloma on 18F-FDG PET\/CT. Hell J Nucl Med. 2015;18:268\u201370.","journal-title":"Hell J Nucl Med"},{"key":"1374_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00408-016-9904-1","volume":"194","author":"C Rapicetta","year":"2016","unstructured":"Rapicetta C, Lococo F, Stefani A, Rossi G, Ricchetti T, Filice A, et al. Primary sarcomatoid carcinoma of the lung: radiometabolic ((18)F-FDG PET\/CT) findings and correlation with clinico-pathological and survival results. Lung. 2016;194:653\u20137.","journal-title":"Lung"},{"key":"1374_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/RLU.0000000000000998","volume":"4","author":"L Jiang","year":"2016","unstructured":"Jiang L, Tan H, Panje CM, Yu H, Xiu Y, Shi H. Role of 18F-FDG PET\/CT imaging in intrahepatic cholangiocarcinoma. Clin Nucl Med. 2016;4:1\u20137.","journal-title":"Clin Nucl Med"},{"key":"1374_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/COC.0000000000000101","volume":"39","author":"Y Lin","year":"2016","unstructured":"Lin Y, Yang H, Cai Q, Wang D, Rao H, Lin S, et al. Characteristics and prognostic analysis of 69 patients with pulmonary sarcomatoid carcinoma. Am J Clin Oncol. 2016;39:215\u201322.","journal-title":"Am J Clin Oncol"},{"key":"1374_CR15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3904\/kjim.2017.245","volume":"33","author":"JK Sim","year":"2018","unstructured":"Sim JK, Chung SM, Choi JH, Oh JY, Lee SH, Kim JH, et al. Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma. Korean J Intern Med. 2018;33:737\u201344.","journal-title":"Korean J Intern Med"},{"key":"1374_CR16","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.athoracsur.2007.03.099","volume":"84","author":"LW Martin","year":"2007","unstructured":"Martin LW, Correa AM, Ordonez NG, Roth JA, Swisher SG, Vaporciyan AA, et al. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis. Ann Thorac Surg. 2007;84:973\u201380.","journal-title":"Ann Thorac Surg"},{"key":"1374_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1586\/17476348.2016.1157475","volume":"10","author":"E Shum","year":"2016","unstructured":"Shum E, Stuart M, Borczuk A, Wang F, Cheng H, Halmos B. Recent advances in the management of pulmonary sarcomatoid carcinoma. Expert Rev Respir Med. 2016;10:1\u201310.","journal-title":"Expert Rev Respir Med"},{"key":"1374_CR18","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1002\/ijc.24610","volume":"125","author":"A Italiano","year":"2009","unstructured":"Italiano A, Cortot AB, Ilie M, Martel-Planche G, Fabas T, Pop D, et al. EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy. Int J Cancer. 2009;125:2479\u201382.","journal-title":"Int J Cancer"},{"key":"1374_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/his.13505","volume":"73","author":"M Mehrad","year":"2018","unstructured":"Mehrad M, Roy S, LaFramboise WA, Petrosko P, Miller C, Incharoen P, et al. KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma. Histopathology. 2018;73:207\u201314.","journal-title":"Histopathology"},{"key":"1374_CR20","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jtho.2016.04.020","volume":"11","author":"F Lococo","year":"2016","unstructured":"Lococo F, Gandolfi G, Rossi G, Pinto C, Rapicetta C, Cavazza A, et al. Deep sequencing analysis reveals that KRAS mutation is a marker of poor prognosis in patients with pulmonary sarcomatoid carcinoma. J Thorac Oncol. 2016;11:1282\u201392.","journal-title":"J Thorac Oncol"},{"key":"1374_CR21","doi-asserted-by":"publisher","first-page":"e0175622","DOI":"10.1371\/journal.pone.0175622","volume":"12","author":"K Takamochi","year":"2017","unstructured":"Takamochi K, Mogushi K, Kawaji H, Imashimizu K, Fukui M, Oh S, et al. Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma. PLoS One. 2017;12:e0175622.","journal-title":"PLoS One"},{"key":"1374_CR22","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1097\/RLU.0000000000000975","volume":"40","author":"SM Lee","year":"2015","unstructured":"Lee SM, Bae SK, Jung SJ, Kim CK. FDG uptake in non-small cell lung cancer is not an independent predictor of EGFR or KRAS mutation status: a retrospective analysis of 206 patients. Clin Nucl Med. 2015;40:950\u20138.","journal-title":"Clin Nucl Med"},{"key":"1374_CR23","doi-asserted-by":"publisher","first-page":"52792","DOI":"10.18632\/oncotarget.17782","volume":"8","author":"R Minamimoto","year":"2017","unstructured":"Minamimoto R, Jamali M, Gevaert O, Echegaray S, Khuong A, Hoang CD, et al. Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET\/CT metrics. Oncotarget. 2017;8:52792\u2013801.","journal-title":"Oncotarget"},{"key":"1374_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/JTO.0b013e318292be18","volume":"8","author":"V Velcheti","year":"2013","unstructured":"Velcheti V, Rimm D, Schalper KA. Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1). J Thorac Oncol. 2013;8:803\u20135.","journal-title":"J Thorac Oncol"},{"key":"1374_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.lungcan.2017.09.009","volume":"113","author":"F Lococo","year":"2017","unstructured":"Lococo F, Torricelli F, Rossi G, Alifano M, Damotte D, Rapicetta C, et al. Inter-relationship between PD-L1 expression and clinic-pathological features and driver gene mutations in pulmonary sarcomatoid carcinomas. Lung Cancer. 2017;113:93\u2013101.","journal-title":"Lung Cancer"},{"key":"1374_CR26","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s12032-010-9515-2","volume":"28","author":"CY Mu","year":"2011","unstructured":"Mu CY, Huang JA, Chen Y, Chen C, Zhang XG. High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation. Med Oncol. 2011;28:682\u20138.","journal-title":"Med Oncol"},{"key":"1374_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.lungcan.2018.03.001","volume":"119","author":"N Kasahara","year":"2018","unstructured":"Kasahara N, Kaira K, Bao P, Higuchi T, Arisaka Y, Erkhem-Ochir B, et al. Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma. Lung Cancer. 2018;119:71\u20137.","journal-title":"Lung Cancer"},{"key":"1374_CR28","doi-asserted-by":"publisher","first-page":"e0146195","DOI":"10.1371\/journal.pone.0146195","volume":"11","author":"J Liu","year":"2016","unstructured":"Liu J, Dong M, Sun X, Li W, Xing L, Yu J. Prognostic value of 18F-FDG PET\/CT in surgical non-small cell lung cancer: a meta-analysis. PLoS One. 2016;11:e0146195.","journal-title":"PLoS One"},{"key":"1374_CR29","first-page":"3091","volume":"24","author":"Yoo IeR","year":"2014","unstructured":"IeR Yoo, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, et al. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET\/CT in early stage non-small cell lung cancer patients without LN metastasis. Biomed Mater Eng. 2014;24:3091\u2013103.","journal-title":"Biomed Mater Eng"},{"key":"1374_CR30","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.3747\/co.26.4167","volume":"26","author":"M Dosani","year":"2019","unstructured":"Dosani M, Yang R, McLay M, Wilson D, Liu M, Yong-Hing CJ, et al. Metabolic tumour volume is prognostic in patients with non-small-cell lung cancer treated with stereotactic ablative radiotherapy. Curr Oncol. 2019;26:e57\u201363.","journal-title":"Curr Oncol"},{"key":"1374_CR31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/MNM.0000000000000671","volume":"38","author":"L Evangelista","year":"2017","unstructured":"Evangelista L, Cervino AR, Michieletto S, Saibene T, Ghiotto C, Guarneri V, et al. Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET\/CT in preoperative and postoperative setting of breast cancer patients. Nucl Med Commun. 2017;38:537\u201345.","journal-title":"Nucl Med Commun"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-019-01374-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-019-01374-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-019-01374-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T23:25:52Z","timestamp":1591226752000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-019-01374-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1374"],"URL":"https:\/\/doi.org\/10.1007\/s12149-019-01374-5","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,5]]},"assertion":[{"value":"26 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}